Implications of Centers for Medicare & Medicaid Services Severe Sepsis and Septic Shock Early Management Bundle and Initial Lactate Measurement on the Management of Sepsis
- PMID: 29804795
- PMCID: PMC6113629
- DOI: 10.1016/j.chest.2018.03.025
Implications of Centers for Medicare & Medicaid Services Severe Sepsis and Septic Shock Early Management Bundle and Initial Lactate Measurement on the Management of Sepsis
Abstract
Background: Sepsis remains a significant cause of morbidity and mortality in the United States, leading to the implementation of the Severe Sepsis and Septic Shock Early Management Bundle (SEP-1). SEP-1 identifies patients with "severe sepsis" via clinical and laboratory criteria and mandates interventions, including lactate draws and antibiotics, within a specific time window. We sought to characterize the patients affected and to study the implications of SEP-1 on patient care and outcomes.
Methods: All adults admitted to the University of Chicago from November 2008 to January 2016 were eligible. Modified SEP-1 criteria were used to identify appropriate patients. Time to lactate draw and antibiotic and IV fluid administration were calculated. In-hospital mortality was examined.
Results: Lactates were measured within the mandated window 32% of the time on the ward (n = 505) compared with 55% (n = 818) in the ICU and 79% (n = 2,144) in the ED. Patients with delayed lactate measurements demonstrated the highest in-hospital mortality at 29%, with increased time to antibiotic administration (median time, 3.9 vs 2.0 h). Patients with initial lactates > 2.0 mmol/L demonstrated an increase in the odds of death with hourly delay in lactate measurement (OR, 1.02; 95% CI, 1.0003-1.05; P = .04).
Conclusions: Delays in lactate measurement are associated with delayed antibiotics and increased mortality in patients with initial intermediate or elevated lactate levels. Systematic early lactate measurement for all patients with sepsis will lead to a significant increase in lactate draws that may prompt more rapid physician intervention for patients with abnormal initial values.
Keywords: critical care; lactic acid; sepsis; septic shock.
Copyright © 2018 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
Figures




Comment in
-
Lactate Measurements: A Guide to Therapy or to Quality?Chest. 2018 Dec;154(6):1461. doi: 10.1016/j.chest.2018.07.041. Chest. 2018. PMID: 30526976 No abstract available.
-
Response.Chest. 2018 Dec;154(6):1462. doi: 10.1016/j.chest.2018.08.1025. Chest. 2018. PMID: 30526977 No abstract available.
References
-
- Liu V., Escobar G.J., Green J.D. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA. 2014;312:90–92. - PubMed
-
- Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546–1554. - PubMed
-
- Angus D.C., Line-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303–1310. - PubMed
-
- Dellinger R.P., Levy M.M., Rhodes A., Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637. - PubMed
-
- Specifications Manual for National Hospital Inpatient Quality Measures Discharges 10-01-15 (4Q15) through 06-30-16 (2Q16). Specifications manual for National Inpatient Quality Measures. The Joint Commission. 2016.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical